Article info
Benefits to nonparticipants
Paper
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
- Correspondence to Dr Rahul Kumar, Department of Philosophy, Queen's University, Kingston, Ontario, Canada K7L 3N6; rahul.kumar{at}queensu.ca
Citation
Contractualist reasoning, HIV cure clinical trials, and the moral (ir)relevance of the risk/benefit ratio
Publication history
- Received January 18, 2016
- Revised August 11, 2016
- Accepted August 17, 2016
- First published September 2, 2016.
Online issue publication
January 25, 2017
Article Versions
- Previous version (2 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Other content recommended for you
- The morality of risks in research: reflections on Kumar
- Challenge studies of human volunteers: ethical issues
- Ethical guidelines for deliberately infecting volunteers with COVID-19
- How to keep high-risk studies ethical: classifying candidate solutions
- When should conscientious objection be accepted?
- Intuitions, principles and consequences
- Moral dimensions
- The unwitting sacrifice problem
- A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations
- Good parents would not fulfil their obligation to genetically enhance their unborn children